127 related articles for article (PubMed ID: 34747634)
1. Genetic polymorphisms in the
Hao R; Han P; Zhang L; Bi Y; Yan J; Li H; Bai Y; Xu C; Li B; Li H
Future Oncol; 2021 Dec; 17(34):4677-4686. PubMed ID: 34747634
[No Abstract] [Full Text] [Related]
2. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
3. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
4. Suggestive evidence of the genetic association of TMOD1 and PTCSC2 polymorphisms with thyroid carcinoma in the Chinese Han population.
Tong K; Zhang C; Yang T; Guo R; Wang X; Guan R; Jin T
BMC Endocr Disord; 2022 Oct; 22(1):263. PubMed ID: 36316666
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study yields five novel thyroid cancer risk loci.
Gudmundsson J; Thorleifsson G; Sigurdsson JK; Stefansdottir L; Jonasson JG; Gudjonsson SA; Gudbjartsson DF; Masson G; Johannsdottir H; Halldorsson GH; Stacey SN; Helgason H; Sulem P; Senter L; He H; Liyanarachchi S; Ringel MD; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Xu L; Kiemeney LA; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Kristvinsson H; Netea-Maier RT; Jonsson T; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Thorsteinsdottir U; Rafnar T; de la Chapelle A; Stefansson K
Nat Commun; 2017 Feb; 8():14517. PubMed ID: 28195142
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in IL1R1 and IL1R2 are associated with susceptibility to thyroid cancer in the Chinese Han population.
Xiong Z; Sun Y; Wu J; Niu F; Jin T; Li B
J Gene Med; 2019 Jun; 21(6):e3093. PubMed ID: 31021479
[TBL] [Abstract][Full Text] [Related]
7. IL1A & IL1B genetic polymorphisms are risk factors for thyroid cancer in a Chinese Han population.
Li H; Duan N; Zhang Q; Shao Y
Int Immunopharmacol; 2019 Nov; 76():105869. PubMed ID: 31499272
[TBL] [Abstract][Full Text] [Related]
8. The effect of VAV3 polymorphisms on thyroid cancer.
Ren W; Xu C; Wang S; Li H; Dai H; Yang F; Shao Y; Bai Y
Endocrine; 2022 Jan; 75(1):178-184. PubMed ID: 34292486
[TBL] [Abstract][Full Text] [Related]
9. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.
Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K
Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979
[TBL] [Abstract][Full Text] [Related]
10. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
11. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
[TBL] [Abstract][Full Text] [Related]
13. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
[TBL] [Abstract][Full Text] [Related]
14. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
Zhu J; Qi P; Li Z
Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Li H; Dai H; Li H; Li B; Shao Y
Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
[TBL] [Abstract][Full Text] [Related]
16. IL-1RN gene polymorphisms reduces thyroid cancer risk in Chinese Han population.
Li H; Wu Y; Zhao R; Chen X; Ren W; Li H; Han P; Shao Y; Wang J
Mol Carcinog; 2020 Oct; 59(10):1140-1146. PubMed ID: 32790111
[TBL] [Abstract][Full Text] [Related]
17. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
18. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.
Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY
Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714
[TBL] [Abstract][Full Text] [Related]
19. Assessing thyroid cancer risk using polygenic risk scores.
Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206
[TBL] [Abstract][Full Text] [Related]
20. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.
Xu L; Morari EC; Wei Q; Sturgis EM; Ward LS
J Clin Endocrinol Metab; 2012 Jun; 97(6):1913-21. PubMed ID: 22438227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
